BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (JULY – AUGUST 2015)

Clinical Trials – A Timely Matter

Nassim Azzi

Introduction: No one would argue the fact that the costs of clinical trials are rocketing – especially in the US. The cost of developing a drug is rising faster than the rate of inflation due to the length and complexity of clinical trials.
Sonal Singh, M.D., M.P.H, Assistant Professor of Medicine, Health Policy and Management, and International Health, at John Hopkins University, shared some thoughts on reducing the length of clinical trials. He says, “Focus on trials that maximize pharmaceutical profit with societal good. We can get away from a lot of ‘me too’ clinical trials that are non-informative by relying on previous systematic reviews.” Indeed, Singh believes systematic reviews help achieve focus. 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright © KONGPOSH PUBLICATIONS Pvt. Ltd.